Mario Roselli at Tor Vergata University - Research Interests, Publications & Academic Profile

Mario Roselli

UNIVERSITY TOR VERGATA

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Bangladeshi students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

90%

Pharmacology

60%

Oncology

60%

Cancer Therapy

50%

Cancer Biology

50%

Targeted Therapy

50%

Neoadjuvant Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?

Article Link

Year:

2024

Drug recommendation ranking for personalized medicine using outcomes of retrospective cancer patients

Article Link

Year:

2024

Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy

Article Link

Year:

2024

Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine

Article Link

Year:

2024

Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives

Article Link

Year:

2023

The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies

Article Link

Year:

2023

Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?

Article Link

Year:

2023

Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab

Article Link

Year:

2023

Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Article Link

Year:

2023

Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

Article Link

Year:

2022

Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview

Article Link

Year:

2022

NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series

Article Link

Year:

2022

The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Article Link

Year:

2022

MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review

Article Link

Year:

2022

Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review

Article Link

Year:

2022

Collaborators11

Roberto Bei

ITALY

augusto orlandi

Professor

Università degli Studi di Roma La Sapienza

ITALY

Leonardo Palombi

ITALY

Francesco Torino

University of Rome Tor Vergata

ITALY

Giovanna DEL VECCHIO BLANCO

UNIVERSITY TOR VERGATA

ITALY

Fabio Massimo Zanzotto

University of Rome Tor Vergata

ITALY

Marco Caricato

Full Professor of Surgery

Università Campus Bio-Medico di Roma

ITALY

Rolando M. D'Angelillo

Professore Associato

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

Fiorella Guadagni

full professor

Università Telematica San Raffaele Roma Srl

ITALY

FABIO CIANCHI

Full Professor

University of Florence

ITALY

Giovanni Barillari

University of Rome Tor Vergata

ITALY

How do Bangladeshi students reach out?

Meet Kite AI